|
⚲
|
| Keyboard |
| Besthof Robert
✚
|
|
|---|---|
| CIK # | 0001864650 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001864650] | |
| 4 | [0001864650] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Besthof Robert | |
| NRX Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option · derivative
|
2022-03-08 | Grant | 100,000 | $2.61 | 261,000 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-09-15 | Sell | 40,000 | $11.76 | 470,400 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-08-16 | Option exercise | 63,710 | $0.20 | 12,742 |
|
NRX Pharmaceuticals Inc NRXP
Restricted Stock Units · derivative
|
2021-08-16 | Grant | 36,290 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-08-16 | Conversion | 100,000 | $0.20 | 20,000 |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-05-24 | Grant | 347,200 | ||
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-05-24 | Grant | 347,200 |